APOE4 gene-targeting small molecules (Selonterra/Axxam)

N/A

Report date: 2025/01/26 17:34:10
NME

Base Information

Drug NameAPOE4 gene-targeting small molecules (Selonterra/Axxam)
Drug Alias Namemodulators of targets altered by NRF1-APOE4 binding (Selonterra)Alzheimer's disease therapeutics (Selonterra)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein E4 modulators
TargetsApolipoprotein E4
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelonterra Llc
China Registration ClassN/A

Develop Information

Active CompaniesAxxam SpaSelonterra Llc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A